NRG Oncology study of atezolizumab and chemoradiation for patients with limited-stage small cell lung cancer completes accrual - News-Medical.Net

7/8/2022 12:00:00 AM2 years 9 months ago

The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with limited-stage small cell lung cancer (SCLC) recently reached the trial's accrual goal of 506 patie…

The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with limited-stage small cell lung cancer (… [+3447 chars]

full article...